In 2023, Medipal Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Medipal Holdings has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medipal Holdings’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Medipal Holdings amounted to 74,991 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Medipal Holdings decreased by 1.44%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2023, the total Scope 1 emissions of Medipal Holdings were 28,439 metric tons of CO₂ equivalent (tCO₂e). a
Since 2018, Medipal Holdings's Scope 1 emissions have decreased by 21.1%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Medipal Holdings's Scope 1 emissions decreased by 5.81%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
In 2023, Medipal Holdings reported Scope 2 greenhouse gas (GHG) emissions of 46,552 tCO₂e without specifying the calculation method. a
Since 2018, Medipal Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 11.49%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), Medipal Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Medipal Holdings 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, Medipal Holdings reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Medipal Holdings reported 14,255,621 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of Medipal Holdings includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, up from 1 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a
In 2023, Medipal Holdings reported total Scope 3 emissions of 14,255,621 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 95.68% of these emissions originated from upstream activities such as purchased goods and capital goods, while 4.32% came from downstream activities like product use, distribution, and end-of-life treatment. a
Since 2018, Medipal Holdings's Scope 3 emissions have increased by 43,688%, reflecting a rising long-term trend in Scope 3 emissions over time. a b
Compared to the previous year (2022), Medipal Holdings's Scope 3 emissions increased by 36,561.92%, suggesting that the company faced challenges in reducing emissions across its value chain. a b
In 2023, Medipal Holdings reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2023, the largest contributors to Medipal Holdings's Scope 3 emissions were: a
In 2023, Medipal Holdings reported Scope 1 greenhouse gas (GHG) emissions of 28,439 tCO₂e and total revenues of USD 25,225 millions. This translates into an emissions intensity of 1.13 tCO₂e per millions USD. a
In 2023, Medipal Holdings reported a Scope 1 emissions intensity of 1.13 tCO₂e per millions USD. Compared to the peer group median of 4.79 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Medipal Holdings ranked 6 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Medipal Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
In 2023, Medipal Holdings reported a total carbon footprint of 14,330,612 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 12,364.87% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a b
The largest contributor to Medipal Holdings's total carbon footprint was Scope 3 emissions, accounting for 99.48% of the company's total carbon footprint, followed by Scope 2 emissions at 0.32%. a